Immune modulation through silencing-RNA oligonucleotide technology
Vendor Organization : Zyrnat Biotherapeutics, S.L. / Spain 
Type of Organization : Spin off, Start up
Type of Tech Offer : Product
Current Development Status : Research or Experimental
Required business relationship : Joint venture agreement
Sector : Biotechnology, Healthcare, Pharmaceutical
Domains of Knowledge : Life sciences
Tags : Co-stimulation, solid organ transplantation, silencing-RNA, autoimmune disease, organ rejection





